Kidney problems: latest news

Kidney problems resources

  • Longer-term side-effects

    Effective HIV treatment has significantly reduced the risk of serious kidney disease in people with HIV. However, most anti-HIV drugs can cause some damage to the kidneys, so...

    From: Booklets

    Information level Level 2
  • Other tests

    Blood pressure is the force that the beating heart causes in the arteries, veins, and blood vessels that carry blood around the body. Blood pressure is measured...

    From: Booklets

    Information level Level 2
  • Side effects

    The most common side effects are the result of your body getting used to a new drug. After a few weeks, these side effects usually...

    From: The basics

    Information level Level 1
  • Health checks

    Staff at your HIV clinic use various tests to keep an eye on your HIV. Many of these tests are done on samples of your...

    From: The basics

    Information level Level 1
  • The kidneys

    The kidneys are bean-shaped organs, about the size of an adult fist, located one on each side, around the middle of the back, just below...

    From: Factsheets

    Information level Level 2
  • Kidney toxicity

    The kidneys are two organs that sit in the small of the back on either side of the spinal cord. The kidneys filter toxic substances from...

    From: HIV treatments directory

    Information level Level 4
  • Renal (kidney) disease

    Information on kidney disease, including its causes, symptoms and treatment....

    From: HIV treatments directory

    Information level Level 4

Kidney problems features

Kidney problems news from aidsmap

More news

Kidney problems news selected from other sources

  • A question of timing: A lawsuit claims Gilead Sciences could have developed a less-harmful version of its HIV treatment sooner

    More than a decade ago, researchers at Gilead Sciences thought they had a breakthrough: a new version of the company’s key HIV medicine that was less toxic to kidneys and bones. But in 2004 Gilead executives stopped the research, only to restart it as the expiration of tenofovir’s patent in 2018 neared.

    30 May 2016 | Los Angeles Times
  • HIV-infected organs transplanted at Birmingham hospital

    A Birmingham hospital has successfully transplanted two HIV infected organs into patients also suffering from the disease. Liver transplants, from two separate donors, were carried out at the Queen Elizabeth Hospital, in Edgbaston, in the pioneering procedures. Whilst one patient donated both kidneys in surgery performed at Guy’s Hospital, in London.

    19 May 2016 | Birmingham Mail
  • In a first, liver and kidney from HIV-infected donor are transplanted into HIV-positive patients

    In a first that gives HIV-positive patients yet another chance for long lives, surgeons at Johns Hopkins University Medical Center have transplanted a kidney and a liver from a deceased donor who was positive for HIV into two HIV-positive recipients.

    31 March 2016 | Los Angeles Times
  • Johns Hopkins approved to perform first HIV-positive to HIV-positive organ transplants in U.S.

    Johns Hopkins recently received approval from the United Network for Organ Sharing to be the first hospital in the United States to perform HIV-positive to HIV-positive organ transplants. The institution will be the first in the nation to do an HIV-positive kidney transplant and the first in the world to execute an HIV-positive liver transplant.

    09 February 2016 | Johns Hopkins Medicine
  • NIH publishes criteria for research on organ transplantation between people with HIV infection

    ​In a Federal Register notice on Nov. 25, 2015, the U.S. Department of Health and Human Services published safeguards and criteria for research to assess the safety and effectiveness of solid organ transplantation from donors with HIV infection to recipients with HIV infection.

    27 November 2015 | National Institutes of Health
  • TAF and TDF Compared for Kidney, Bone Toxicity in Black HIV+ Patients

    Including tenofovir alafenamide (TAF) in single-tablet elvitegravir/cobicistat/emtricitabine (E/C/F/TAF) is associated with reduced renal and bone toxicity compared to tenofovir disoproxil fumarate (TDF)-containing single-tablet (E/C/F/TDF) therapy, according to an analysis of data from two Phase 3 trials, reported at IDWeek 2015.

    12 October 2015 | Monthly Prescribing Reference
  • Tenofovir Alafenamide Combo Pill Matches Truvada for HIV Efficacy, but Easier on Bones and Kidneys

    A fixed-dose combination pill containing tenofovir alafenamide (TAF) worked as well in a Phase 3 trial as the current Truvada pill containing the older tenofovir disoproxil fumarate (TDF) -- which is used for both HIV treatment and pre-exposure prophylaxis or PrEP -- but causes less kidney and bone toxicity, according to an announcement this week from Gilead Sciences.

    04 September 2015 | HIVandHepatitis.com
  • HHS Establishes Organ Donation Policy for Patients With HIV

    The US Department of Health and Human Services (HHS) has unveiled new regulations to establish a parallel system of organ donation intended to serve patients with the human immunodeficiency virus (HIV).

    11 May 2015 | Regulatory Affairs Professionals Society
  • HIV Patients May Fare as Well as Others With Kidney Transplants

    Kidney transplant patients with HIV have similar survival rates as those without HIV, a new study finds. The study included 510 HIV-positive adults who had kidney transplants in the United States between 2002 and 2011. Overall, these patients had similar five- and 10-year survival rates as kidney transplant patients without HIV.

    20 March 2015 | U.S. News & World Report
  • Tenofovir-based HIV PrEP does not harm kidneys

    Men and women without HIV infection who use tenofovir-based pre-exposure prophylaxis (PrEP) develop significant but not clinically relevant declines in kidney function, according to the largest study to date to look at the issue.

    26 December 2014 | Medscape (requires free registration)
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.

See also